Welcome to our dedicated page for ZIONS BANCORPORATION, NATIONAL ASSOCIATION /UT/ SEC filings (Ticker: ZION), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on ZIONS BANCORPORATION, NATIONAL ASSOCIATION /UT/'s stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into ZIONS BANCORPORATION, NATIONAL ASSOCIATION /UT/'s regulatory disclosures and financial reporting.
Zions Bancorporation, N.A. reported strong results for the quarter ended June 30, 2026, with net earnings to common shareholders of $452 million and diluted EPS of $3.05, or $1.74 excluding notable items. Results were boosted by a $215 million gain on the sale of Visa Class B‑1 shares and $37 million of net unrealized gains from SBIC investments. Net interest income was $677 million, up 4% year over year, and the net interest margin held at 3.27%, up from 3.17% a year earlier. Customer-related noninterest income reached $182 million, an 11% increase, while adjusted pre-provision net revenue was $332 million, up 10% sequentially and 5% year over year; the efficiency ratio was 62.2%.
Loans and leases were $62.5 billion, up 3% from the prior-year quarter, and total deposits were $76.6 billion, up 4%, with the loan-to-deposit ratio steady at 82%. Credit quality remained solid, with annualized net loan and lease charge-offs at 0.06%, nonperforming assets of $298 million or 0.48% of loans and leases and other real estate owned, and an allowance for credit losses of $707 million or 1.13% of loans and leases. Capital improved, as the estimated CET1 ratio was 11.8% and tangible book value per common share rose 22% year over year to $44.74.
Zions Bancorporation director Aaron Skonnard reported a compensation-related grant of deferred compensation units linked to the company’s common stock. He acquired 432.1980 Deferred Comp units at a reference price of $69.19 per unit, bringing his reported Deferred Comp balance to 40,169.2260 units. According to the disclosure, these phantom stock units are settled in cash upon the earlier of death or retirement, rather than delivering actual shares.
QUINN STEPHEN D reported acquisition or exercise transactions in this Form 4 filing.
ZIONS BANCORPORATION director Stephen D. Quinn received a compensation grant of 698.72 phantom stock units under a Deferred Comp arrangement. The award is tied to the value of Zions common stock at a reference price of $69.19 per unit and will be settled in cash upon the earlier of his death or retirement, rather than in actual shares.
Following this grant, Quinn has 129,860.767 phantom stock units reported in this plan. The transaction is classified as a derivative grant or award, not an open-market purchase or sale of Zions common stock.
Huang Claire A reported acquisition or exercise transactions in this Form 4 filing.
Zions Bancorporation director Claire A. Huang reported a compensation-related award of deferred stock units. She received 439.401 "Deferred Comp" phantom stock units linked to Zions common stock at a reference price of $69.19 per unit. These phantom stock units are settled in cash upon the earlier of death or retirement, rather than in actual shares. Following this award, her reported deferred compensation balance tied to common stock increased to 35,394.393 units. This filing reflects a grant or award, not an open-market purchase or sale of Zions stock.
Lee Vivian S reported acquisition or exercise transactions in this Form 4 filing.
Director Vivian S. Lee received a grant of deferred compensation units linked to Zions Bancorporation common stock. The award covers 414.19 deferred comp units, each valued at $69.19, and increases her deferred comp balance to 29,755.913 units. According to the footnote, these phantom stock units are settled in cash upon the earlier of death or retirement.
Ryan Daniel Joseph reported acquisition or exercise transactions in this Form 4 filing.
Zions Bancorporation director Daniel Joseph received a compensation grant of 1,921 deferred compensation units tied to common stock. The units were valued at $62.02 per underlying share on the grant date and are structured as phantom stock, settled in cash upon retirement or death. Following this award, he holds 1,921 such units directly.
Zions Bancorporation director Daniel Joseph Ryan filed an initial Form 3 reporting his beneficial ownership in the company’s common stock. The filing shows he held no shares of Common Stock as of the reported date, and it does not reflect any buy or sell transaction.
Zions Bancorporation Executive Vice President Nathan Callister reported a routine tax-related share disposition. On this Form 4, 922 shares of common stock were withheld at $62.02 per share to cover tax obligations, leaving him with 18,661 directly held shares. This was not an open-market sale.
Zions Bancorporation, N.A. reported that its board of directors increased its size from 11 to 12 members and elected Daniel J. Ryan as a new director, effective immediately. He will serve until the next annual meeting of shareholders.
The board also appointed Ryan to its Audit and Risk Oversight Committees effective July 1, 2026, reflecting his background as a retired PricewaterhouseCoopers partner with more than 40 years of experience advising large U.S. and global banks on governance, risk management, and financial reporting. As a nonemployee director, he will receive cash compensation and participate in the company’s omnibus stock incentive plan.
The company highlighted that there are no related-party transactions with Ryan requiring disclosure under Item 404(a) of Regulation S-K. The attached press release also notes that Zions Bancorporation had approximately $89 billion of total assets at December 31, 2025 and $3.4 billion of annual net revenue in 2025, underscoring its scale as a regional financial services company.
Zions Bancorporation Executive Vice President Jennifer Anne Smith reported an open-market sale of Common Stock held indirectly through a 401(k) plan. She sold 4,209.157 shares at a price of $62.50 per share on May 8, 2026. Following this transaction, the 401(k) plan position reported in this filing holds zero shares.